Filing Details
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE:CRL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 05, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Files Quarterly Report for Q0
Filing Details CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (NYSE:CRL) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 05, 2026. The…
Market Context
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s stock currently trades at $260.72 with a market capitalization of $9.6B.
The 10-Q provides CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CRL Stock Page
Frequently Asked Questions
Where can I read CRL's SEC filings?
Browse all filings on our CRL SEC filings page.
What types of SEC filings does CHARLES RIVER LABORATORIES INTERNATIONAL, INC. file?
Public companies like CHARLES RIVER LABORATORIES INTERNATIONAL, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
